
Popular weight loss drugs Ozempic and Mounjaro hold potential to transform type 1 diabetes treatment: GlobalData
A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro) leads to significant reductions in HbA1c levels and body weight among adults with type 1 diabetes (T1D). The findings of the study were published Diabetes …